Sgo1 is a potential therapeutic target for hepatocellular carcinoma

被引:24
|
作者
Wang, Lyu-Han [1 ]
Yen, Chia-Jui [3 ]
Li, Tian-Neng [1 ]
Elowe, Sabine [2 ]
Wang, Wen-Ching [1 ]
Wang, Lily Hui-Ching [1 ,4 ]
机构
[1] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan
[2] Univ Laval, Fac Med, Dept Pediat & Reprod Perinatal Hlth & Infant Hlth, CHUL CRCHUQ, Quebec City, PQ G1V 4G2, Canada
[3] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan
[4] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan
关键词
Shugoshin; Hepatocellular Carcinoma; Hepatitis B Virus; Large Surface Antigen; Mitosis; Catastrophe; Cohesin; ELEVATED ALPHA-FETOPROTEIN; CHROMOSOMAL INSTABILITY; CHROMATID COHESION; ABNORMAL MITOSIS; ALLELIC LOSS; SHUGOSHIN; CANCER; CELLS; CENTROMERE; VARIANT;
D O I
10.18632/oncotarget.2764
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Shugoshin-like protein 1 (Sgo1) is an essential protein in mitosis; it protects sister chromatid cohesion and thereby ensures the fidelity of chromosome separation. We found that the expression of Sgo1 mRNA was relatively low in normal tissues, but was upregulated in 82% of hepatocellular carcinoma (HCC), and correlated with elevated alpha-fetoprotein and early disease onset of HCC. The depletion of Sgo1 reduced cell viability of hepatoma cell lines including HuH7, HepG2, Hep3B, and HepaRG. Using time-lapse microscopy, we showed that hepatoma cells were delayed and ultimately die in mitosis in the absence of Sgo1. In contrast, cell viability and mitotic progression of immortalized cells were not significantly affected. Notably, mitotic cell death induced upon Sgo1 depletion was suppressed upon inhibitions of cyclin-dependent kinase-1 and Aurora kinase-B, or the depletion of mitotic arrest deficient-2. Thus, mitotic cell death induced upon Sgo1 depletion in hepatoma cells is mediated by persistent activation of the spindle assembly checkpoint. Together, these results highlight the essential role of Sgo1 in the maintenance of a proper mitotic progression in hepatoma cells and suggest that Sgo1 is a promising oncotarget for HCC.
引用
收藏
页码:2023 / 2033
页数:11
相关论文
共 50 条
  • [31] SET binding to Sgo1 inhibits Sgo1-cohesin interactions and promotes chromosome segregation
    Qu, Qianhui
    Zhang, Qian
    Yang, Lu
    Chen, Yujue
    Liu, Hong
    JOURNAL OF CELL BIOLOGY, 2019, 218 (08): : 2514 - 2528
  • [32] SGO1 but not SGO2 is required for maintenance of centromere cohesion in Arabidopsis thaliana meiosis
    Zamariola, L.
    De Storme, N.
    Tiang, C. L.
    Armstrong, S. J.
    Franklin, F. C. H.
    Geelen, D.
    PLANT REPRODUCTION, 2013, 26 (03) : 197 - 208
  • [33] SMPD3 as a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma
    Zhu, Dan
    Cao, Lei
    INTERNATIONAL JOURNAL OF GENOMICS, 2025, 2025 (01)
  • [34] Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma
    Ma, Cheng-Lung
    Hsu, Cheng-Lung
    Wu, Ming-Heng
    Wu, Chun-Te
    Wu, Cheng-Chia
    Lai, Jiann-Jyh
    Jou, Yuh-Shan
    Chen, Chun-Wei
    Yeh, Shuyuan
    Chang, Chawnshang
    GASTROENTEROLOGY, 2008, 135 (03) : 947 - 955
  • [35] Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma
    Tsirulnikov, Kirill
    Duarte, Sergio
    Ray, Anamika
    Datta, Nakul
    Zarrinpar, Ali
    Hwang, Lin
    Faull, Kym
    Pushkin, Alexander
    Kurtz, Ira
    JOURNAL OF CANCER, 2018, 9 (01): : 1 - 12
  • [36] LOXL2: A potential therapeutic target in the treatment of hepatocellular carcinoma?
    Liu, Heng-Xin
    Liu, Lei
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (09) : 1307 - 1307
  • [37] Glypican-3 as a Potential Therapeutic Target for Hepatocellular Carcinoma Immunotherapy
    Trinh, Thu
    Liu, Chen
    FASEB JOURNAL, 2012, 26
  • [38] Validating Aurora B as a potential therapeutic target for human hepatocellular carcinoma
    Lin, Zhong-Zhe
    Jeng, Yung-Ming
    Hsu, Hey-Chi
    Cheng, Ann-Lii
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3501S - 3501S
  • [39] circ_0067934: A Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma
    Zhou, Changdong
    Li, Rui
    Mi, Wei
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2020, 50 (06): : 734 - 738
  • [40] Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma
    Li, Changcan
    Liao, Jianhua
    Wu, Shaohan
    Fan, Junwei
    Peng, Zhihai
    Wang, Zhaowen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 494 (3-4) : 511 - 517